The African Severe Asthma Program (ASAP) is a three year multi country and multi site research project. This GSK funded project is designed to characterise severe asthma among African patients.  The study brings together expertise from four collaborating institutions in Uganda, Kenya, Ethiopia and Netherlands. The four institutions include Makerere University Lung Institute, Addis Ababa University, University of Nairobi and Groningen Research Institute for Asthma and COPD.